Home
ACTL Immunotherapy
Functional Mechanism
Advantages
Safety
Indications
Protocols
Steps
Patents
Translational Medicine
Treatment & Prevent
Conditions
Case Studies
Cooperative Hospital
Early Detection
Prevention
Nursing & Care
News
Partnership
About Us
Company Introduction
Our Culture
Milestones
Qualification & Honor
Team of Experts
Activities
Jobs
Contact Us
简体
繁体
英文
Coperate News
Coperate News
Industrial News
Policies & Regulations
02-03 2021
ACTL靶向性抗肿瘤细胞免疫治疗技术安全性研究
With the increase of life expectancy in our country and the increasing environmental pollution, the...
Details
02-02 2021
Evaluation of the therapeutic effect of ACTL targeted cellular immunotherapy on brain metastases from non-small cell lung adenocarcinoma
A well-known international authoritative journal in the field of clinical lung cancer diagnosis and...
Details
10-11 2017
Technology realizes China's dream, innovation creates the future-ISKCON was invited to participate in the "14th China Scientists Forum" and returned with honor
On September 18, 2017, the 14th Scientist Forum co-sponsored by China Future Research A...
Details
09-27 2017
Technological innovation, gathered together-Shenzhen Yishi Kangning appeared at the 2017 Shenzhen International Biological/Life Health Industry Exhibition
On September 21, 2017, the 2017 Shenzhen International Biology/Life and Health Industry Exh...
Details
04-28 2017
ACTL anti-cancer immune technology goes abroad to establish anti-cancer biological treatment center in Singapore
On April 28, 2017, the signing ceremony of the ACTL technology project cooperation between Sh...
Details
<<
1
2
3
4
5
>>
10
